> fifteen years of experience in pharmaceutical R&D; from drug discovery to early clinical development.
Her career brought Leen to various renowned companies: Johnson & Johnson, 4AZA-Elbion, Movetis, and Shire. The scope of her discovery and early clinical development work was widened from immune-suppressive compounds, gastroenterology, COPD and hepatology. She also built up experience with the implementation of a patient reported outcome as well as the testing of biomarkers. Following the integration of Movetis into Shire, Leen Thielemans co-founded 2Bridge.
Leen is passionate about discovering patterns in complexity, translating them into scenarios to solve a problem.